Pulmonology

Reports of high-impact pulmonology studies by medical professionals

Benralizumab not shown to ameliorate COPD exacerbation rates when compared to placebo

1. Two complementary phase 3 clinical trials randomized patients with moderate-to-severe COPD to receive either benralizumab or a placebo and found that the trial...

Quick Take: Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP)

Corticosteroids are frequently used in the treatment of acute chronic obstructive pulmonary disease (COPD) exacerbations. However, the use of systemic corticosteroids is not without...

Unrecognized obstructive sleep apnea increases risk of postoperative cardiovascular events

1. In this prospective cohort study, severe but not moderate, unrecognized obstructive sleep apnea was associated with increased postoperative cardiovascular events in patients undergoing...

Patent foramen ovale associated with four-fold increased risk for ischemic stroke in patients with...

1. In this prospective cohort study, patients with symptomatic pulmonary embolism (PE) and a patent foramen ovale (PFO) were found to have a significantly...

Quick Take: Discovery and validation of a prognostic proteomic signature for tuberculosis progression

Tuberculosis (TB) is the leading cause of death by an infectious disease. Identifying affected individuals, particularly if they are asymptomatic, however, remains a challenge...

Quick Take: The burden of health conditions for middle-aged and older adults in the...

Understanding the burden of health conditions in older adults in the U.S. is essential in addressing the healthcare demands of this patient population. This...

Internal medicine interns spending minority of time on direct inpatient care

1. In this direct observational study, first year internal medicine residents (interns) spent only 13% of their time on direct patient care, while spending...

No decrease in risk of deep vein thrombosis seen with adjunctive pneumatic compression

1. A randomized control trial of adult ICU patients randomized to receive either adjunct intermittent pneumatic compression with pharmacologic thromboprophylaxis versus pharmacologic thromboprophylaxis only...

Quick Take: Pembrolizumab Versus Chemotherapy for Previously Untreated, PD-L1-Expressing, Locally Advanced or Metastatic Non-Small-Cell...

Pembrolizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1). Previous studies have shown that pembrolizumab is effective in prolonging survival in...

Electronic health record clinical and genomic data provides relevant insights for non-small cell lung...

1. In patients with non-small cell lung cancer (NSCLC), an analysis of clinical and genomic data from routine care replicated previously established relationships between...
licensing as small

All-time hits